Skip to content
HeyJared

Padmanabhan Ananthan

Reporter · US

Indexed articles, last 90 days
1
Latest publication
Aug 10, 2026
Outlet visibility, for Medscape
Top 50K sites
Earliest in this view
Aug 10, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Aug 10, 2026 · Padmanabhan Ananthan

    Eli Lilly's Weight-loss Pill Secures First European Nod in Britain (opens the original)

    Excerpt · Neutral tone · English

    Read excerpt

    Aug 10 (Reuters) - Britain's medicines regulator on Monday authorised Eli Lilly's pill, Foundayo, for weight management and type 2 diabetes, ⁠making it the first country in Europe to green light the treatment for both conditions. "Whilst this tablet is approved for use ⁠in the UK, it is not available currently via the NHS," the Medicines and Healthcare products Regulatory ⁠Agency, or MHRA, said. The approval marks ‌the second GLP-1 oral pill cleared in the UK after Novo secured its nod for the W

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 50K sites

For Medscape, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Padmanabhan Ananthan